Código QR (código de barras bidimensional)

Assessing the clinical outcomes of immunotherapy and docetaxel combinations in metastatic castration-resistant prostate cancer: a meta-analysis

Abstract Background Despite breakthroughs in treatment, metastatic castration-resistant prostate cancer (mCRPC) continues to pose a substantial problem. This meta-analysis sought to assess the efficacy and safety of immunotherapy-chemotherapy combinations in mCRPC. Methods A thorough search of Clini...

ver descrição completa

Na minha lista:
Principais autores: Azka Syed, Hasan Raza, Hameer Khan Khaskheli, Izza Rafique, Sameen Shahid, Nimra Shahzadi, Abdelrahman Sayed Al Komi, Abdullah A. Assiri, Muhammad Abbas Khokhar, Najeeb Ullah Khan
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2025-07-01
coleção:BMC Cancer
Assuntos:
Metastatic castration-resistant prostatic cancer
Immune checkpoint inhibitors
Immunotherapy
Docetaxel
MCRPC
Acesso em linha:https://doi.org/10.1186/s12885-025-14575-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados